Vaccine Production and Global Access

This chapter examines the mass production of a vaccine by an Indian manufacturer, highlighting the Oxford-AstraZeneca formula's importance for low-income countries. It also addresses the challenges of vaccine patents and strategic global partnerships aimed at improving vaccine distribution during the pandemic.